The effectiveness of PD-L1 immunohistochemistry (IHC) in circulating tumor cells from patients with advanced lung cancer: a pilot study.

CytoGen0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年7月12日

试验速览

暂无简介。

•1) Male and female adults over 19 years old.
•2) Lung cancer group : Inoperable non-small cell lung cancer and small cell lung cancer patients who were diagnosed histologically.
•3) respiratory infection group : Patients with respiratory infections such as pneumonia, tuberculosis, and non-tuberculosis mycobacteria were confirmed by microbial tests and radiation.

•1) Male and female adults 19 years of age or older
•2) Lung cancer group: Histologically diagnosed inoperable non-small cell lung cancer and small cell lung cancer.
•3) Respiratory infection group: Patients with confirmed respiratory infections such as pneumonia, tuberculosis, and non-tuberculous mycobacterium by microbiological examination and radiographic findings.
•4) Patients who can comply with the procedure according to this clinical trial protocol and who voluntarily signed the consent form

发起方

CytoGen